항암활성을 가지는 2,4-다이아미노퀴나졸린 화합물
    13.
    发明公开
    항암활성을 가지는 2,4-다이아미노퀴나졸린 화합물 有权
    具有抗病毒活性的2,4-二氨基喹唑啉化合物

    公开(公告)号:KR1020120038034A

    公开(公告)日:2012-04-23

    申请号:KR1020100097911

    申请日:2010-10-07

    Abstract: PURPOSE: A 2,4-diaminoquinazoline compound with anticancer activity is provided to be used as an anticancer agent. CONSTITUTION: A 2,4-diaminoquinazoline compound is denoted by chemical formula 1. A pharmaceutical composition for anticancer contains 2,4-diaminoquinazoline compound of chemical formula 1. A method for preparing the compound of chemical formula 1 comprises: a step of binding 2-chloro-N-(furnylmethyl)quinazoliine-4-amine compounds of chemical formula 2 with an amine compound of chemical formula 3.

    Abstract translation: 目的:提供具有抗癌活性的2,4-二氨基喹唑啉化合物作为抗癌剂。 构成:2,4-二氨基喹唑啉化合物由化学式1表示。抗癌用药物组合物含有化学式1的2,4-二氨基喹唑啉化合物。化学式1化合物的制备方法包括:将2 - 氯-N-(苄基甲基)喹唑啉-4-胺化合物与化学式3的胺化合物。

    4-(2-벤질옥시페닐)-1-(피롤리딘-3-일)-1,2,3-트리아졸 화합물
    15.
    发明公开
    4-(2-벤질옥시페닐)-1-(피롤리딘-3-일)-1,2,3-트리아졸 화합물 有权
    4-(2-苄氧基苯基)-1-(吡咯烷-3-基)-1,2,3-三唑衍生物

    公开(公告)号:KR1020160103390A

    公开(公告)日:2016-09-01

    申请号:KR1020150025825

    申请日:2015-02-24

    CPC classification number: C07D403/04 A61K31/4192 C07D249/04

    Abstract: 본발명은미토콘드리아의기능을조절하여신경보호제로서의약효활성을보이면서동시에사이토크롬 P450 이소자임의활성이저하되어독성을유발하는약물과병용투여시에약물의독성을감소시키는 4-(2-벤질옥시페닐)-1-(피롤리딘-3-일)-1,2,3-트리아졸화합물과, 상기화합물의제조방법, 그리고상기화합물을포함하는약제조성물에관한것이다.

    Abstract translation: 本发明涉及一种4-(2-苄氧基苯基)-1-(吡咯烷-3-基)-1,2,3-三唑化合物及其制备方法以及包含该化合物的药物组合物。 更具体地,4-(2-苄氧基苯基)-1-(吡咯烷-3-基)-1,2,3-三唑化合物通过调节线粒体的功能而显示出作为神经保护剂的药用活性,并降低药物的毒性 当通过降解细胞色素P450同功酶的活性而给药引起毒性的药物时。

    세로토닌 5-HT6 저해 활성을 갖는 5-설포닐아미노-5,6-다이하이드로-1H-피라졸로[3,4-c]피리딘-7(4H)-온 화합물
    17.
    发明公开
    세로토닌 5-HT6 저해 활성을 갖는 5-설포닐아미노-5,6-다이하이드로-1H-피라졸로[3,4-c]피리딘-7(4H)-온 화합물 有权
    新型5-磺酰氨基-5,6-二氢-1H-吡唑并[3,4-C]吡啶-7(4H) - 酮化合物,其具有丝氨酸5-HT6的抑制活性

    公开(公告)号:KR1020140118141A

    公开(公告)日:2014-10-08

    申请号:KR1020130033552

    申请日:2013-03-28

    Abstract: The present invention relates to a novel 5-sulfonylamino-5,6-dihydro-1H-pyrazolo[3,4-c]pyridin-7(4H)-one compound having an inhibitory activity for 5-HT6, which is one of serotonin subtypes, and a pharmaceutical composition comprising the compound as an active ingredient. Since the novel compound of the present invention has 5-HT6 inhibitory activities, the compound can be used for diagnosing, preventing, and treating central nervous system (CNS) diseases such as Alzheimer′s disease (AD), attention deficit disorder (ADHD), epilepsy, depression, obesity, schizophrenia, sleep disorders, and pain disorders.

    Abstract translation: 本发明涉及对5-HT6具有抑制活性的新的5-磺酰基氨基-5,6-二氢-1H-吡唑并[3,4-c]吡啶-7(4H) - 酮化合物,其为5-羟色胺 亚型和包含该化合物作为活性成分的药物组合物。 由于本发明的新化合物具有5-HT 6抑制活性,所以该化合物可用于诊断,预防和治疗中枢神经系统(CNS)疾病如阿尔茨海默病(AD),注意缺陷障碍(ADHD) ,癫痫,抑郁症,肥胖,精神分裂症,睡眠障碍和疼痛障碍。

    5―HT7 수용체에 작용하는 바이페닐 아마이드 유도체
    20.
    发明公开
    5―HT7 수용체에 작용하는 바이페닐 아마이드 유도체 有权
    在5-HT7受体上起作用的联苯胺衍生物

    公开(公告)号:KR1020130102828A

    公开(公告)日:2013-09-23

    申请号:KR1020120023966

    申请日:2012-03-08

    Inventor: 추현아 김영재

    Abstract: PURPOSE: A biphenyl amide derivative is provided to show superior activity as a neuroprotective agent which functions on mitochondria and to be used as an effective agent for preventing and treating central nervous system disorders. CONSTITUTION: A biphenyl amide derivative is denoted by chemical formula 1. A method for preparing the derivative comprises the steps of bonding a compound of chemical formula 2 and a compound of chemical formula 3. A pharmaceutical composition which functions on 5-HT_7 receptor contains the biphenyl compound of chemical formula 1 or a pharmaceutically acceptable salt thereof as an active ingredient.

    Abstract translation: 目的:提供联苯酰胺衍生物作为在线粒体上起作用并用作预防和治疗中枢神经系统疾病的有效药物的神经保护剂的优异活性。 组成:联苯酰胺衍生物由化学式1表示。制备衍生物的方法包括将化学式2的化合物和化学式3的化合物键合的步骤。在5-HT_7受体上起作用的药物组合物含有 化学式1的联苯化合物或其药学上可接受的盐作为活性成分。

Patent Agency Ranking